跳至主要内容
临床试验/NCT03099681
NCT03099681招募中不适用

Epithelioid Sarcoma. An Observational Study

Italian Sarcoma Group11 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2017年8月22日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
100
试验地点
11
主要终点
Type of treatment given to patients with ES

研究概览

简要总结

Prospective Italian study aimed to provide a description of the population affected by Epithelioid Sarcoma (ES)

详细描述

The present prospective national study aims to provide a description of the population affected by ES, an insight into the natural history of the disease and an answer some on the outstanding questions on its management. Also, it will focus on enhancing any differences between the two ES variants (classical-type and proximal-type) in order gain a better understanding of the disease, tailor the treatment and lastly improve outcome.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Type of treatment given to patients with ES

时间窗: From diagnosis until the date of death from any cause assessed up to 60 months

Number of chemotherapy treatment received patients affected by ES

次要结局

  • Predictive biomarkers for response(At time of diagnosis and at the time of any progression where a biopsy is performed up to 60 months)
  • Radiotherapy treatments(From the time of diagnosis and then every 6 months up to 60 months)
  • Chemotherapy treatments(From the time of diagnosis and then every 6 months up to 60 months)

研究者

申办方类型
Network
责任方
Sponsor

研究点 (11)

Loading locations...

相似试验